网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
头颈部肿瘤放疗后血行感染发生情况及其危险因素分析
作者:古丽娜尔·吐尔地  朱成斌  赵辉  迪丽努尔·尼加提 
单位:新疆维吾尔自治区人民医院 放疗中心, 新疆 乌鲁木齐 830001
关键词:头颈部肿瘤 放疗 血行感染 预测模型 
分类号:R739.91
出版年·卷·期(页码):2022·50·第九期(1109-1113)
摘要:

目的:分析头颈部肿瘤放疗后血行感染的发生情况及其危险因素,构建感染风险预测模型,并对其诊断效能进行验证。方法:将2019年1月至2021年12月于我院行放疗的476例头颈部肿瘤患者纳入研究,根据患者是否出现血行感染将其分为感染组及对照组,比较两组患者的一般资料、临床特征及相关实验室指标,采用多因素Logistic回归模型分析影响放疗后感染的因素,并使用R软件建立放疗后感染的列线图预测模型,并对其进行Bootstrap内部验证。结果:与对照组患者相比,感染组患者年龄较大,住院时间较长,行侵入性操作患者比例、患者主观整体评估(PG-SGA)评分及中性粒细胞水平较高,白蛋白水平较低(均P<0.05);多因素Logistics回归分析示高龄、高PG-SGA评分、住院时间过长及侵入性操作是影响感染发生的独立危险因素,而高白蛋白水平则是保护因素(均P<0.05);列线图预测放疗后感染发生的一致性指数为0.947,校正曲线显示列线图模型预测感染与实际观察的相关性较好。结论:基于年龄、侵入性操作及白蛋白水平等因素构建的列线图可有效对头颈部肿瘤患者放疗后血行感染的发生进行预测,并具有较好的应用价值。

参考文献:

[1] BADR H, SOBRERO M, CHEN J, et al.Associations between pre-, post-, and peri-operative variables and health resource use following surgery for head and neck cancer[J].Oral Oncol, 2019, 90:102-108.
[2] CHI A C, DAY T A, NEVILLE B W.Oral cavity and oropharyngeal squamous cell carcinoma——an update[J].CA Cancer J Clin, 2015, 65(5):401-421.
[3] BARTON M B, JACOB S, SHAFIQ J, et al.Estimating the demand for radiotherapy from the evidence:a review of changes from 2003 to 2012[J].Radiother Oncol, 2014, 112(1):140-144.
[4] ALFOUZAN A F.Radiation therapy in head and neck cancer[J].Saudi Med J, 2021, 42(3):247-254.
[5] GAUBATZ M E, BUKATKO A R, SIMPSON M C, et al.Racial and socioeconomic disparities associated with 90-day mortality among patients with head and neck cancer in the United States[J].Oral Oncol, 2019, 89:95-101.
[6] HAMILTON S N, TRAN E, BERTHELET E, et al.Early(90-day) mortality after radical radiotherapy for head and neck squamous cell carcinoma:a population-based analysis[J].Head Neck, 2018, 40(11):2432-2440.
[7] TALANI C, MAKITIE A, BERAN M, et al.Early mortality after diagnosis of cancer of the head and neck-a population-based nationwide study[J].PLoS One, 2019, 14(10):e0223154.
[8] JENSEN K H, VOGELIUS I, KRISTENSEN C A, et al.Early mortality after radical radiotherapy in head and neck cancer-a nationwide analysis from the Danish Head and Neck Cancer Group(DAHANCA) database[J].Clin Oncol(R Coll Radiol), 2021, 33(1):57-63.
[9] GILLISON M L, TROTTI A M, HARRIS J, et al.Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer(NRG Oncology RTOG 1016):a randomised, multicentre, non-inferiority trial[J].Lancet, 2019, 393(10166):40-50.
[10] TERRONES C C, LEDERGERBER B, VOGELIUS I R, et al.Lymphocyte count kinetics, factors associated with the end-of-radiation-therapy lymphocyte count, and risk of infection in patients with solid malignant tumors treated with curative-intent radiation therapy[J].Int J Radiat Oncol Biol Phys, 2019, 105(4):812-823.
[11] JENSEN K H, VOGELIUS I, MOSER C E, et al.Bloodstream infections in head and neck cancer patients after curative-intent radiotherapy:a population-based study from the Danish Head and Neck Cancer Group database[J].Br J Cancer, 2021, 125(3):458-464.
[12] Chinese Society of Clinical Oncology(CSCO) diagnosis and treatment guidelines for head and neck cancer 2018(English version)[J].中国癌症研究(英文版), 2019, 31(1):84-98.
[13] 石英英, 张晓伟, 袁凯涛, 等.PG-SGA操作标准介绍[J].中华肿瘤防治杂志, 2013, 20(22):1779-1782.
[14] KONINGS H, STAPPERS S, GEENS M, et al.A literature review of the potential diagnostic biomarkers of head and neck neoplasms[J].Front Oncol, 2020, 10:1020.
[15] KAWASHITA Y, FUNAHARA M, YOSHIMATSU M, et al.A retrospective study of factors associated with the development of oral candidiasis in patients receiving radiotherapy for head and neck cancer:is topical steroid therapy a risk factor for oral candidiasis?[J].Medicine(Baltimore), 2018, 97(44):e13073.
[16] ESME M, TOPELI A, YAVUZ B B, et al.Infections in the elderly critically-ill patients[J].Front Med(Lausanne), 2019, 6:118.
[17] TANNOU T, KOEBERLE S, MANCKOUNDIA P, et al.Multifactorial immunodeficiency in frail elderly patients:contributing factors and management[J].Med Mal Infect, 2019, 49(3):167-172.
[18] KUBECEK O, PATEROVA P, NOVOSADOVA M.Risk factors for infections, antibiotic therapy, and its impact on cancer therapy outcomes for patients with solid tumors[J].Life(Basel), 2021, 11(12):1387-1411.
[19] CHEN B, LIU W, CHEN Y, et al.Effect of poor nutritional status and comorbidities on the occurrence and outcome of pneumonia in elderly adults[J].Front Med(Lausanne), 2021, 8:719530.
[20] ZHANG Q, LI X R, ZHANG X, et al.PG-SGA SF in nutrition assessment and survival prediction for elderly patients with cancer[J].BMC Geriatr, 2021, 21(1):687.
[21] 王长玲.营养状况对老年住院患者发生医院感染的影响[J].中国临床医生杂志, 2019, 47(2):196-198.
[22] 邝敏齐, 沈梅英, 卢换璋.患者住院时间与医院感染发生的关系分析[J].中国当代医药, 2013, 20(21):179-180.
[23] ASLAM S, VAIDA F, RITTER M, et al.Systematic review and meta-analysis on management of hemodialysis catheter-related bacteremia[J].J Am Soc Nephrol, 2014, 25(12):2927-2941.
[24] 高飞, 张卫青, 梁首勤, 等.血清白蛋白、前白蛋白和转铁蛋白在评价慢性肝衰竭患者营养支持中的应用[J].实用医学杂志, 2017, 33(4):603-605.
[25] 赵改, 谢杰, 刘飞, 等.术前血C反应蛋白与白蛋白比值、老年营养风险指数在老年髋部骨折患者预后评估中的价值[J].东南大学学报(医学版), 2021, 40(1):103-107.
[26] 蔡奋, 马长春, 蔡晓锐, 等.白蛋白球蛋白比值、放疗剂量及同期放化疗联合预测鼻咽癌患者口腔真菌医院感染的价值[J].现代预防医学, 2018, 45(22):4213-4217.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 601128 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541